Intellia Therapeutics Inc. (NTLA) is one of the largest holdings in the iShares Russell 2000 exchange-traded fund (IWM) and one Real Money subscriber wonders if this stock can help the IWM break out of its long, sideways trading range. The company is a pioneer in the development of CRISPR/Cas9 genome editing.
More from Investing
We now have worries about the Fed raising rates while bonds are acting like the economy is going to slow dramatically.
Let's uncover the Alpha Architect Inflation and Deflation exchange-traded fund.
The shares have recently failed at the underside of the declining 200-day moving average line.
We have a price target for this infrastructure engineering software firm.
This is typical bear market action in which stock picking doesn't matter much, and macro considerations are driving the indexes -- still, I've got a pick.